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Human cytomegalovirus is a ubiquitous pathogen that infects the majority of the world’s
population. After long period of time co-evolving with human being, this pathogen has
developed several strategies to evade host immune surveillance. One of the major trick is
encoding homologous to those of the host organism or stealing host cellular genes that have
signiﬁcant functions in immune system. To date, we have found several viral immune anal-
ogous  which include G protein coupled receptor, class I major histocompatibility complex
and  chemokine. Chemokine is a small group of molecules which is deﬁned by the presence
of  four cysteines in highly conserved region. The four kinds of chemokines (C, CC, CXC, and
CX3C)  are classiﬁed based on the arrangement of 1 or 2 N-terminal cysteine residues. UL128
protein is one of the analogous that encoded by human cytomegalovirus that has simi-
lar  amino acid sequences to the human CC chemokine. It has been proved to be one of the
essential particles that involved in human cytomegalovirus entry into epithelial/endothelial
cells as well as macrophages. It is also the target of potent neutralizing antibodies in human
cytomegalovirus-seropositive individuals.
We  had demonstrated the chemotactic trait of UL128 protein in our previous study. Recom-
binant UL128 in vitro has the ability to attract monocytes to the infection region and enhances
peripheral blood mononuclear cell proliferation by activating the MAPK/ERK signaling path-
way.  However, the way that this viral encoded chemokine interacting with peripheral blood
mononuclear cells and the detailed mechanism that involving the virus entry into host cells
keeps unknown. Here we performed in vitro investigation into the effects of UL128 protein
on  peripheral blood mononuclear cell’s activation and receptor binding, which may helpus  further understand the immunomodulatory function of UL128 protein as well as humancytomegalovirus diffusion
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Introduction
Human cytomegalovirus (HCMV) is a ubiquitous pathogen
that infects the majority of the world population.1 The infec-
tion caused by HCMV in the human body can be lifelong.
HCMV has developed several strategies to evade host immune
surveillance over a long period time of co-evolution with
human beings. The major tricks are to encode proteins that
are homologous to those of the host organism or to steal host
cellular genes that has signiﬁcant functions in the immune
system.2 The potential roles of these immune analogous in
virus trafﬁcking, persistence, and immune evasion remain
largely unknown.
To date, we  have found several viral immune analo-
gous which include G protein coupled receptor, class I
major histocompatibility complex (MHC-I) and chemokines.3
Chemokines are a small group of molecules, which are deﬁned
by the presence of four cysteines in highly conserved region.
The four kinds of chemokines (C, CC, CXC, and CX3C) are
classiﬁed based on the arrangement of 1 or 2 N-terminal cys-
teine residues.4 UL128 protein is one of the analogous encoded
by HCMV, which has similar amino acid sequences to the
human CC chemokine. It proved to be one of the essential
particles involved in HCMV entry into epithelial/endothelial
cells as well as macrophages.5 UL128 protein is also the target
of potent neutralizing antibodies (NAb) in HCMV-seropositive
individuals.6
We  had demonstrated the chemotactic trait of UL128 pro-
tein in a previous study.7 Recombinant UL128 in vitro has the
ability to attract monocytes to the infection site and enhances
peripheral blood mononuclear cells (PBMC) proliferation by
activating the MAPK/ERK signaling pathway, which may con-
tribute to virus dissemination from one infectious organ to
other susceptible organs.8 However, the way that this viral
encoded chemokine interacting with PBMC and the detailed
mechanism involved in virus entry into host cells needs fur-
ther study. Here we  performed an in vitro investigation of the
effects of UL128 protein on PBMC activation and receptor bind-
ing, which may further strengthen the immunomodulatory
function of UL128 protein and contribute to better understand
HCMV diffusion mechanism.
Material  and  methods
Expression  and  puriﬁcation  of  recombinant  UL128  protein
Recombinant UL128 protein was obtained as reported
previously.7 The UL128 gene sequence position 1243-2003
was selected from the Genbank (Accession no: GU574790.1).
UL128 gene product was cloned using the pIRES-AcGFP
vector (Qiagen, Valencia, CA) and was employed for the
bacterial expression of pIRES-AcGFP with a 6-Histag fused
to its N-terminus. Chinese hamster ovary cells were used
for production of recombinant UL128 protein and the tar-
get protein was obtained through His·Bind Kit (Novagen,
Germany). Protein concentration was quantiﬁed using the
Bradford assay (Biorad) according to the manufacturer’s
instruction. 1 5;1  9(4):403–409
Western  blot
Since recombinant UL128 protein was labeled by 6-Histag,
western blot analysis was carried out using 6 × His Rabbit
Polyclonal Antibody (Epitomics, Cat.: S2917) to conﬁrm the
presence of UL128 protein. The puriﬁed recombinant UL128-
histag from SDS PAGE was transferred to PVDF (polyvinylidene
diﬂuoride) membrane. The membrane was blocked in 5%
defatted milk dissolved in PBST (PBS containing 0.5% Tween-
20) with gentle shaking at room temperature for 2 h. The
membrane was incubated in a 1:1000 dilution of rabbit
anti-his-polyclonal antibody in blocking buffer with gentle
shaking at room temperature for 1 h, then changed to 4 ◦C
overnight. After washing with PBST three times for 10 min
each, the membrane was incubated in a 1:2000 dilution of
sheet anti-rabbit IgG horseradish peroxidase (HRP) conjugated
as secondary antibody (Epitomics, Cat.: 3053-1) in blocking
buffer, with gentle shaking at room temperature for 1 h after
the membrane was washed with PBST for three times.
Silver  stain
Silver stain was applied to detect trace amounts of proteins in
gels. (1) Fixed: after electrophoresis (see above of SDS-PAGE),
the gel was put in 100 mL  ﬁxative liquid and shook for 20 min  at
room temperature, placing overnight to further reduce back-
ground; (2) Washing: remove the from the ﬁxed liquid, add
100 mL of 30% ethanol and shake for 10 min  at room tem-
perature. Discard ethanol, add 200 mL  double distilled water
and shake for 10 min  at room temperature; (3) Sensitization:
remove water, then add 100 mL  silver staining sensitizing solu-
tion (1×),  shake for 2 min  at room temperature at a shaking
speed of 60–70 rpm (revolutions per minute); (4) Silver staining:
add 100 mL  silver solution (1×),  shake for 10 min  at a shak-
ing speed of 60–70 rpm, and washed by double distilled water
for 1 min; (5) Color: discard water, add 100 mL  silver stain-
ing solution, shake for 3–10 min  until the ideal protein band
appears; (6) Termination: remove from silver staining solution,
add 100 mL  silver staining terminated liquid (1×),  shake for
10 min  at room temperature, and washed by double distilled
water for 2 min.
Peripheral  blood  mononuclear  cell  (PBMC)  culture
PBMC from whole blood of healthy volunteers were isolated
by standard density centrifugation (Ficoll Separation Solution:
GIBCO, Germany). The mononuclear cells were collected and
washed twice in phosphate-buffered saline (PBS, pH 7.2). By
adjusting to 1 × 106 cells/mL, the cells were re-suspended in
MEM medium with 10% heated-activated fetal calf serum.
Informed consents were provided before sample collection.
Measurement  of  calcium  concentration
As immune cells activation is countered by calcium ﬂuxion,
the intracellular calcium concentration in response to UL128
was monitored using ﬂuo-3 AM (Calbiochem; La Jolla, CA USA)
in PBMCs. The PBMC calcium level was determined by ﬂow
cytometry (Millipore, easyCyte8). Cells were pre-treated with
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Fig. 1 – Silver stain of recombinant UL128 protein. M:
Marker, L1: Supernatant of CHO-Vector, L2: Puriﬁcation
lipid of CHO-Vector supernatant, L3: Blank control, L4:
Supernatant of CHO-UL128; L5: Puriﬁcation lipid of
CHO-UL128 supernatant, rUL128: Western Blot of
recombinant UL128 (using anti-Histag).b r a z j i n f e c t d i s .
r without 10 M ﬂuo-3 AM (intracellular calcium chelator)
or 1 h, then washed with PBS and diluted to 5 × 106 cells/mL
n Hank’s balanced salt solution containing Ca2+ and Mg2+
nd 1% FBS. Different concentrations of U.L128 were added to
00 nM and incubated at 37 ◦C for 30 min, and then analyzed
y ﬂow cytometry. Relative intra-cellular calcium levels were
easured as the ratio of emissions at 490 nm to the emissions
t 400 nm according to the manufacturer’s instructions.
ross-linking  assay
he cross-linking assay was used to prove the ability of UL128
rotein to bind the membrane receptor of PBMC and com-
are with the positive control MIP-1.  PBMC (1 × 107 cells/mL)
ere suspended in MEM  medium pretreated with recom-
inant UL128 (10 ng/mL) or MIP-1(10 ng/mL) for 24 h then
ade into slides. Slides were washed four times with D-
anks (100 nmol/L) containing 0.5% BSA and ﬁxed with 4%
araformaldehyde for 20 min. Slides were incubated with
ither anti-UL128 antibody (1:200, supplied by HangZhou Neu-
oPeptide Biological Science and Technology Incorporation)
r rabbit anti-MIP-1antibody (Rockland, 109-401-315) or nor-
al  rabbit serum at room temperature for 45 min. Slides were
ashed four times with D-hanks and incubated with biotin-
onjugated goat anti-rabbit IgG (1:200) at room temperature for
0 min. The results were observed under microscope by count-
ng the positive cells. The experiment was repeated three
imes for data analysis.
uantitative  real-time  PCR  (qPCR)
PCR analyses were performed to quantify the CC recep-
or gene expression. Puriﬁed recombinant UL128 protein was
o-cultured with PBMC for 24 h before CC receptor detec-
ion. PBS added in PBMC was used as negative control and
IP-1 co-cultured PBMC was tested as positive control. Con-
erved regions at appropriate distances of CC receptors were
sed for designing the primers employed in qPCR reactions
Table 1). This was achieved using Primer Express 3.0 soft-
are.  Total RNA was extracted using the RNeasy kit (Qiagen).
NA concentration and purity was estimated using a NanoVue
pectrophotometer and assessed for quality using agarose gel
Table 1 – Primers of CC chemokine receptors.
Gene Locus 
CCR1 Exon2 (61–481) Forward: GAC
Reverse: GTAG
CCR2 Exon1 (1–434) Forward: ACA
Reverse: GTG
CCR3 Exon1 (238–780) Forward: CAG
Reverse: ACTA
CCR4 Exon2 (118–660) Forward: CCA
Reverse: GAA
CCR5 Exon2 (58–346) Forward: GGC
Reverse: GATelectrophoresis. Total RNA (2 mg)  was reverse transcribed to
cDNA using the Fermentas First Strand Synthesis kit (Invi-
trogen). Ampliﬁcations were performed in an ABI Prism 7500
sequence detection system (Applied Biosystems). Fifteen L
reactions were prepared in clear 96 well fast plates. Ampliﬁ-
cation mixture concluded with the Maxima SYBR Green qPCR
Master Mix (2×) (Thermo Scientiﬁc, USA), and a 0.2 M end
concentration of each of the forward and reverse primers,
267 nM Rox, and 25 ng template cDNA. Ampliﬁcation was car-
ried out with a preliminary 2 min  UDG pretreatment at 50 ◦C
followed by a 10 min  initial denaturation at 95 ◦C, followed
by 40 cycles of denaturation for 15 s at 95 ◦C and anneal-
ing/extension for 60 s at 60 ◦C. Each experiment contains no
template and no reverse transcriptase controls.
Statistical  analyses
Results from real-time PCR and FCM were derived from at
least three independent experiments. Statistical signiﬁcance
between siRNA and control groups was evaluated with one-
way ANOVA followed by the Dunnett post-test using the
Prism3 GraphPad software. Signiﬁcance level was calculated
using an assigned conﬁdence interval of 95%. p < 0.05 was con-
sidered signiﬁcant.
Primer sequences Product size (bp)
TATGACACGACCACAGA
ATGGAGGACTTGGACCGGTAA
225
GGAGCAGATGTACAG
ATCATCCTCTCGTCTCT
253
GAGGCTCCGAATTATGA
TGGTCTCGTGACTACC
180
CGGATATAGCAGACACC
CTCCTCGGACATCTCAA
450
TGAAGAGCATGACTGAC
GGACGAGTTGGACCGGT
403
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Table 2 – Concentration of puriﬁed UL128 protein.
Standard (mg/mL) Standard OD value ( = 570 nm) Sample OD value (UL128 puriﬁcation) Sample concentration (mg/mL)
0 0.542 0.602 0.022
0.05 0.595 0.620 0.040
0.1 0.686 0.621 0.040
0.2 0.823 0.601 0.020
0.25 0.898 0.668 0.085
0.3 0.971 0.592 0.013
0.4 0.942 0.625 0.044
0.5 1.069 0.661 0.078
Standard curve: Y = 1.0557X + 0.5782 (R2 = 0.93); Take three of the highest concentration of UL128 puriﬁcation liquid and condensed them into
0.1 mg/mL and saved at −20 ◦C for use.
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Fig. 2 – Sample1: The negative control group (PBMC + Fluo-3/AM). Fluorescent indicator did not detect signiﬁcant Ca2+ when
PBMC without treatment factor. Sample2: The positive control group (PBMC + Fluo-3/AM + MIP-1). Intracellular Ca2+
concentration increased instantly when adding MIP-1 in the cell-culture medium. Sample3: The experimental group
(PBMC + Fluo-3/AM + UL128). The level of intracellular Ca2+ concentration was markedly increased after treatment of UL128.
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esults
uriﬁcation  of  recombinant  UL128  protein
he rUL128 production system was successfully constructed
y using eukaryotic expression vector (pIRES-AcGFP-UL128)
ith 6× His-Tag fused to its N-terminal, then transferred into
hinese Hamster Ovary (CHO) cell line. Puriﬁed rUL128 was
bout 26 kilodalton (KD) and was condensed into 0.1 mg/mL
Table 2). Silver stain experiment conﬁrmed high puriﬁcation
f the destined protein (Fig. 1). As shown in the ﬁgure, the red
rrow refers to puriﬁed recombinant UL128 protein, which was
onsistent with western blot analysis.
nduction  of  calcium  transients  in  PBMC
hemotactic agonists induce a rapid and transient rise of Ca2+
n target cells. Our experiment showed that UL128 protein
ncreased Ca2+ in PBMC at chemotactic concentrations which
as similar to the function of MIP-1  (Fig. 2).
nteracting  with  the  membrane  receptor  of  PBMC
mmunohistochemistry results of cross-linking assay showed
L128 protein binding the cytomembrane receptors of PBMC.
uman CC chemokine (MIP-1)  was used as positive control.
he mean percentage of positive cells that UL128 and MIP-
binding with PBMC were 13% and 12.6%, respectively (Fig. 3).
here was no signiﬁcant difference between them (p > 0.05).
MIP-1α (400x)MIP-1α (200x)
UL128 (400x)UL128 (200x)
BLANK (400x)BLANK (200x)
ig. 3 – UL128 binding the cytomembrane receptor of PBMC.
LANK: puriﬁcation elute of CHO-Vector supernatant
negative control), MIP-1:  10 ng/mL (positive control),
L128: 10 ng/mL. White arrows in the picture indicate the
ositive cells.5;1 9(4):403–409 407
Expression  of  chemokine  receptors  in  PBMC
In our experiment, UL128 protein could enhance production
of CC chemokine receptors (CCR) according to PCR detection.
CCR1, CCR3, and CCR4 were up-regulated when PBMC was
co-cultured with UL128 at low concentration (10 ng/mL). Tran-
scription of CCR2 and CCR5 were improved with the increase
of UL128 concentration, but they could hardly be detected with
UL128 at low concentration. Based on these results, we  infer
that HCMV encoded UL128 protein may interact with different
kinds of CCRs of PBMC and active at low concentration (Fig. 4).
Discussion
The study further proved the immune modulatory function
of a viral encoded CC chemokine (HCMV UL128). This viral
encoded protein not only has similar structure, but also has
similar function to the human CC chemokine MIP-1,  which
is called chemokine mimics. In vitro, UL128 has the ability
to attract PBMCs which is equal to that of MIP-1  and its
chemotactic effect does not increase with the increasing of
concentrations, which were shown in our previous study.7,8
Immune modulators regulate immunity through a series
of complex processes with related polypeptides. Recep-
tor binding is the ﬁrst step of activation of immune
cells. Chemokines exert their functions by interacting with
seven-trans-membrane domain receptors expressed in dif-
ferent immune cell types, thus producing different types of
inﬂammation.9 Here we demonstrated that HCMV encoded
UL128 played a role in receptor binding and activation of PBMC.
Calcium ﬂux was observed in PBMC after addition of UL128
at chemotactic concentration (10 ng/mL), which conﬁrms that
recombinant UL128 has the ability to activate PBMC in vitro.
Moreover, both immunochemistry and PCR results demon-
strated the capacity of UL128 to interact with the cell surface
receptors of PBMC. Straschewski et al. reported that soluble
UL128 protein (1000 ng/mL) in vitro could block migration of
monocytes by down-regulation of CCR1, CCR2 and CCR5 com-
paring with monocytes infected with wild type of HCMV.10
Nonetheless, in our study recombinant UL128 could enhance
the production of CCR1 as well as CCR3 and CCR4 at low
concentration (10 ng/mL) which may correlate with its chemo-
tactic function such as recruiting PMBC to the infectious site. It
was predicted that only expression of chemokines at low levels
in anatomically restricted areas could produce leukocytic inﬁl-
tration consistent with their in vitro properties.4 The artiﬁcial
high concentration of molecules in vitro may cause inhibitory
effect by itself. Based on the above ﬁndings, we  speculate that
UL128 may combine with a variety of CC chemokine recep-
tors and different concentrations of UL128 could enhance the
expression of different receptors so as to having diverse inﬂu-
ences to human immune cells. This may explain our previous
ﬁndings why UL128 protein exerts chemotactic function with-
out concentration dependence.
So far, ﬁve diverse functions of chemokine mim-
ics have been identiﬁed: anti-chemokines; cell-entry fac-
tors; cell-growth factors; angiogenic factors and leukocyte
chemoattractants.11 According to our studies, HCMV encoded
UL128 acts as a chemokine agonist in vitro recruiting
408  b r a z j i n f e c t d i s . 2 0 1 5;1  9(4):403–409
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Fig. 4 – Rt-PCR detection of CC chemokine receptors in PBMC.
rpreferred host cells (leukocytes) to the site of infection and
possibly to ensure viral latency at low concentration, and may
cause imbalance of host immune system simultaneously. CC
chemokine receptors 1, 3 and 4 may be involved in this process.
The CC chemokine receptors have overlapping speciﬁcities,
which makes the receptor–ligand research more  confusing.
Moreover, study of chemokines in vitro may not be enough
to predict their in vivo properties. Recently, a genetic demon-
stration for the critical role of human -chemokine MIP-1
in viral disease has been shown. Mice engineered to be deﬁ-
cient in MIP-1  show none of the presumably autoimmune
myocarditis linked with Coxsackie virus infection. Similarly,
pulmonary inﬂammatory responses to inﬂuenza virus were
alleviated.12 They suggest that MIP-1  plays an irreplaceable
role in the inﬂammatory responses to infection and clear-
ance of virus. This may explain why HCMV encoded UL128
mimic  human chemokine MIP-1.  Next step, we will move
on to the detailed mechanism by which chemokine mim-
ics and related pathology in the end organ damage of HCMV
infection.Conﬂicts  of  interest
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